NAD+ biosynthesis metabolism predicts prognosis and indicates immune microenvironment for breast cancer
Authors:
Open Access
- 17 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Pathology and Oncology Research
- Vol. 29
Abstract
The growing evidence implies that tumor cells need to increase NAD+ levels by upregulating NAD+ biosynthesis to satisfy their growth demand. NAD+ biosynthesis metabolism is implicated in tumor progression. Breast cancer (BC) is the most common malignant malignancy in the world. Nevertheless, the prognostic significance of NAD+ biosynthesis and its relationship with the tumor immune microenvironment in breast cancer still need further investigation. In this study, we obtained the mRNA expression data and clinical information of BC samples from public databases and calculated the level of NAD+ biosynthesis activity by single-sample gene set enrichment analysis (ssGSEA). We then explored the relationship between the NAD+ biosynthesis score, infiltrating immune cells, prognosis significance, immunogenicity and immune checkpoint molecules. The results demonstrated that patients with high NAD+ biosynthetic score displayed poor prognosis, high immune infiltration, high immunogenicity, elevated PD-L1 expression, and might more benefit from immunotherapy. Taken together, our studies not only deepened the understanding of NAD+ biosynthesis metabolism of breast cancer but also provided new insights into personalized treatment strategies and immunological therapies to improve the outcomes of breast cancer patients.Keywords
This publication has 54 references indexed in Scilit:
- Concurrent Gene Signatures for Han Chinese Breast CancersPLOS ONE, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Genomic grade adds prognostic value in invasive lobular carcinomaAnnals of Oncology, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- DNA methylation profiling reveals a predominant immune component in breast cancersEMBO Molecular Medicine, 2011
- STATs in cancer inflammation and immunity: a leading role for STAT3Nature Reviews Cancer, 2009
- Adjusting batch effects in microarray expression data using empirical Bayes methodsBiostatistics, 2006
- The ETS Transcription Factor Spi-B Is Required for Human Plasmacytoid Dendritic Cell DevelopmentJournal of Experimental Medicine, 2004
- affy—analysis of Affymetrix GeneChip data at the probe levelBioinformatics, 2004
- PU.1 and Spi-B Are Required for Normal B Cell Receptor–Mediated Signal TransductionImmunity, 1999